Aria Pharmaceuticals
Anjali Pandey is the SVP of Non-Clinical R&D & Chemistry at Aria Pharmaceuticals. She's an executive leader with 25+ years of experience in CSO/SVP roles through all stages of discovery through launch.
Anjali previously served as SVP of Medicinal Chemistry & Chemical Development at Portola Pharmaceuticals, where she managed discovery and CMC for Bevyxxa™ and Cerdulatinib.
Most recently, Anjali held CSO/EVP positions at BridgeBio Pharma subsidiaries TheRas and Ferro Therapeutics. Anjali has published over 45 scientific publications and is an inventor on 60 issued U.S. patents.
She holds an MS from the Indian Institute of Technology, a Ph.D. from Southern Illinois University, and completed her postdoctoral fellowship at SRI International.
This person is not in any offices
Aria Pharmaceuticals
1 followers
Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel small molecule therapies for complex and hard-to-treat diseases.